3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Radiation Injuries
1
Breast Neoplasms
1
Interventions
Specimen Handling
84
Magnetic Resonance Spectroscopy
83
Cyclophosphamide
77
pembrolizumab
64
Radiotherapy
58
Nivolumab
55
fludarabine
47
Cisplatin
45
Biopsy
41
Carboplatin
40
Standard of Care
36
Dexamethasone
33
Rituximab
30
Radiation
30
Bevacizumab
30
Radiosurgery
29
Temozolomide
28
Gemcitabine
28
Surveys and Questionnaires
27
Doxorubicin
27
Cytarabine
27
Paclitaxel
26
venetoclax
25
fludarabine phosphate
25
Blood Specimen Collection
25
Practice Guidelines as Topic
24
Ipilimumab
24
Interviews as Topic
21
Fluorouracil
21
atezolizumab
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymph Node Excision
×
30 days
×
Clear all
NCT04889924
2026-05-19
ADARNAT
Hospital Universitari de Bellvitge
Phase NA
Recruiting
820 enrolled